ArticlePostepy w kardiologii interwencyjnej = Advances in interventional cardiology2026
A single-center, mid-term study evaluating the efficacy of branched stent grafts in the treatment of aortic arch pathology in non-urgent patients.
Article in Postepy w kardiologii interwencyjnej = Advances in interventional cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Branched thoracic endovascular aortic repair (bTEVAR) is a method enabling the treatment of complex aortic arch pathologies in patients who are not eligible for open surgery. This single-center study evaluated the medium-term results of aortic arch pathology treatment using the bTEVAR method. Aim: To evaluate the technical feasibility, safety and mid-term outcomes of bTEVAR technique for complex aortic arch pathologies in non-urgent patients. Material and methods: The study included 15 patients treated with double- and triple-branched stent grafts based on specific criteria. Treatment evaluation was performed using computed tomography angiography. Technical success, perioperative complications, and follow-up results were assessed. Results: Technical success was achieved in 12 (80%) patients. Within 30 days after the procedure, 1 (6.7%) death and 2 (13.3%) strokes, 1 of which was non-disabling, were observed. During the follow-up period, which averaged 15.6 months (median: 10 months, range: 0-47 months), endoleaks were observed in 3 patients, 2 of whom required reintervention. Three patients required further treatment due to progression of aortic pathology. No retrograde type A dissection, stent-graft-induced new entry, or stent-graft infection was observed. Conclusions: The bTEVAR technique using double- and triple-branched stent grafts in the treatment of patients with aortic arch pathology is a relatively effective method that prevents arch degeneration and offers acceptable medium-term results. This method can only be used by experienced vascular units due to the high risk of neurological complications and postoperative mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.